Tbesc 3 - denver health and hospital authority

Ended Definitive Contract Awarded Last action

Contract number
75D30121C12877
Awardee
Awarding agency
Obligated
$4,668,988

Award facts

Opportunity
Contract value 100% obligated
$4,679,587.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Atlanta, GA 30329, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · Rescission of termination for convenience $0
Terminate for Convenience P00012 · EOI::implementing the president's doge cost efficiency initiative::EOI notice of termination for convenience?? $0
Exercise an Option P00011 $1,204,051
Other Administrative Action P00010 -$610,797
Exercise an Option P00008 $1,190,462
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Exercise an Option P00005 $1,185,773
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $1,699,499
Show all 13

About this award

The Centers for Disease Control and Prevention (CDC) awarded a $4,679,587.20 Definitive Contract to the Denver Health and Hospital Authority (Denver Health) to develop, implement, and evaluate intervention studies to improve identification of latent tuberculosis infection (LTBI) and treatment-to-cure for high-risk non-U.S.-born populations in primary care settings. This contract, which does not have a set-aside designation, has a period of performance from September 29, 2021 through March 28, 2026. Denver Health, a comprehensive 555-bed academic healthcare system in Denver, Colorado, has extensive experience supporting federal healthcare and research objectives, including multiple Indefinite Delivery Vehicle (IDV) contracts with the CDC and Food and Drug Administration (FDA) for vaccine safety monitoring, drug use surveillance, and data analytics. This contract aligns with the CDC's broader efforts to address tuberculosis infection among high-risk populations.

Quick answers

Who was awarded contract 75D30121C12877?

75D30121C12877 was awarded to Denver Health And Hospital Authority by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 29, 2021.

How much is contract 75D30121C12877 worth?

The government has obligated $4,668,988 on 75D30121C12877. Its current value, with exercised options, is $4,679,587.

Was contract 75D30121C12877 competed?

The extent of competition for 75D30121C12877 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award